マーケットレポート詳細

ワクチン技術の世界市場：2026年予測

Global Markets for Vaccine Technologies

出版元：BCC Research　 出版元について
発行年：2021年11月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文188ページになります。
商品コード：BCC338

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

ワクチン技術の世界市場規模は2021年に382億ドル、2026年には551億ドルへと漸増する見通しです。同期間の市場の平均年成長率は7.6%とレポートは分析しています。
ワクチン市場は、新たな感染症、がん、アレルギー疾患などに対する技術的な進化をベースに成長が見込まれます。ワクチン設計、送達技術、製造の継続的進化も市場成長を支えるでしょう。
ワクチンで予防できる疾病の再増加、新たなパンデミックの勃発、新興国における免疫化プログラムはワクチン市場に影響を与える要因となります。

当レポートでは、ワクチン技術の市場/技術的背景、COVID-19ワクチンの世界市場、市場ダイナミクス、各種セグメント別市場分析(技術別、疾患別、年齢層別、国地域別)、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術的背景

・定義
・免疫システムとワクチン
・ワクチンと免疫化、概要
・免疫
・アジュバンドおよび賦形剤
・ワクチンで予防できる感染症
・ヒトの病気
・規制動向

◆COVID-19ワクチンの世界市場

・概要
・COVID-19ワクチン技術
・mRNA技術の出現
・乳児の定期予防接種に対するCOVID-19の影響
・COVID-19による混乱
・世界の接種率の停滞
・国および地域別の進捗状況と課題

◆市場ダイナミクス

・ドライバー
・障壁
・機会
・競合状況

◆ワクチン技術市場、技術別

ワクチンタイプ別
・サブユニット/組換え/多糖類および結合型ワクチン
・弱毒性ワクチン
・不活化ワクチン
・トキソイドワクチン
・その他/混合ワクチン
※市場予測データ-2026年掲載

◆ワクチン技術市場、疾患別

・肺炎球菌
・ジフテリアと破傷風
・HPV
・MMR
・その他
※市場予測データ-2026年掲載

◆ワクチン技術市場、年齢層別

・小児科
・青年および成人
※市場予測データ-2026年掲載

◆ワクチン技術市場、地域別

北米
・米国、カナダ
欧州
・ドイツ、ロシア、フランス
・英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、オーストラリア、インド、韓国
・その他アジア太平洋
その他地域
※市場予測データ-2026年掲載
※地域別にワクチンタイプ別、疾患別のデータ掲載
※国別にワクチンタイプ別のデータ掲載

◆主要企業プロフィール

・ABBOTT LABORATORIES
・ASTRAZENECA
・BAVARIAN NORDIC A/S
・BHARAT BIOTECH INTERNATIONAL LTD.
・EMERGENT BIOSOLUTIONS INC.
・GLAXOSMITHKLINE PLC
・JOHNSON & JOHNSON INC.
・MERCK & CO. INC
・田辺三菱製薬株式会社
・PANACEA BIOTEC LTD.
・PFIZER INC.
・SANOFI PASTEUR SA

(全188頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update
COVID-19 Update
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Definitions
Immune System and Vaccines

History of Vaccines
Vaccines and Immunization, Overview

Immunization

Adjuvants and Excipients

Infectious Diseases Preventable by Vaccine
Human Diseases

Regulatory Aspects

Chapter 4 Global Market for COVID-19 Vaccines

Overview
COVID-19 Vaccine Technologies
Advent of mRNA Technology
Impact of COVID-19 on Routine Infant Vaccination
COVID-19 Disruptions
Stagnating Global Coverage Rate
Progress and Challenges by Country and Region

Chapter 5 Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Competitive Landscape

Chapter 6 Market Breakdown by Technology

Global Market for Vaccine Technologies by Vaccine Type

Chapter 7 Market Breakdown by Disease

Global Market for Vaccine Technologies by Disease

Chapter 8 Market Breakdown by Age Group Treated

Global Market for Vaccine Technologies by Age Group Treated

Chapter 9 Market Breakdown by Region

Global Market for Vaccine Technologies by Region

Chapter 10 Company Profiles

ABBOTT LABORATORIES
ASTRAZENECA
BAVARIAN NORDIC A/S
BHARAT BIOTECH INTERNATIONAL LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON INC.
MERCK & CO. INC
MITSUBISHI TANABE PHARMA CORP.
PANACEA BIOTEC LTD.
PFIZER INC.
SANOFI PASTEUR SA

Chapter 11 Appendix: List of Acronyms

List of Tables

Table A : Changes in the Segmentation of the Old and Updated Versions of This Report
Summary Table A : Global Market for Vaccine Technologies, by Vaccine Type, Through 2026
Summary Table B : Global Market for COVID-19 Vaccines, Through 2026
Table 1 : History of Vaccines
Table 2 : Types of Attenuated (Live) Vaccines
Table 3 : Pros and Cons of Attenuated (Live) Vaccines
Table 4 : Types of Inactivated (Killed) Vaccines
Table 5 : Pros and Cons of Inactivated (Killed) Vaccines
Table 6 : Types of Toxoid Vaccines
Table 7 : Pros and Cons of Toxoid Vaccines
Table 8 : Types of Subunit Vaccines
Table 9 : Pros and Cons of Subunit Vaccines
Table 10 : Types of Conjugate Vaccines
Table 11 : Pros and Cons of Conjugate Vaccines
Table 12 : Types of Recombinant Vector Vaccines, by Segment
Table 13 : Pros and Cons of Recombinant Vector Vaccines
Table 14 : Types of DNA Vaccines, by Segment
Table 15 : Pros and Cons of DNA Vaccines
Table 16 : Pros and Cons of RNA Vaccines
Table 17 : Vaccine Excipient and Media Summary, Excipients included in U.S. Vaccines
Table 18 : Vaccine-Preventable Human Viral Diseases
Table 19 : Vaccine-Preventable Human Bacterial Diseases
Table 20 : WHO Prequalified Vaccines, Jan. 2014–April 2020
Table 21 : Newly Approved Vaccines, Jan. 2014–April 2020
Table 22 : Global Vaccine Recalls, by Manufacturer, Jan. 2014-Nov. 2017
Table 23 : Global Vaccine Shortage, by Manufacturer, Jan. 2012–Nov. 2017
Table 24 : Global Market for COVID-19 Vaccines, Through 2026
Table 25 : WHO Approved COVID-19 Vaccines: Companies and Technology Adopted
Table 26 : COVID-19 Vaccines in the Pipeline
Table 27 : Emerging Viral Infectious Diseases, 1900-2020
Table 28 : Global Market for Vaccine Technologies, by Vaccine Type, Through 2026
Table 29 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, by Region, Through 2026
Table 30 : Global Market for Live-Attenuated Vaccines, by Region, Through 2026
Table 31 : Global Market for Inactivated Vaccines, by Region, Through 2026
Table 32 : Global Market for Toxoid Vaccines, by Region, Through 2026
Table 33 : Global Market for Other/Combination Vaccines, by Region, Through 2026
Table 34 : Vaccines, by Disease Type
Table 35 : Global Market for Vaccine Technologies, by Disease, Through 2026
Table 36 : Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, Through 2026
Table 37 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, Through 2026
Table 38 : Global Market for Vaccine Technologies for HPV, by Region, Through 2026
Table 39 : Global Market for Vaccine Technologies for MMR, by Region, Through 2026
Table 40 : Seasonal Influenza Vaccines
Table 41 : Global Market for Vaccine Technologies for Other Diseases, by Region, Through 2026
Table 42 : Global Market for Vaccine Technologies, by Age Group Treated, Through 2026
Table 43 : Pediatric Vaccine Doses
Table 44 : Pediatric/VFC Vaccine Price List, 2019
Table 45 : Influenza Vaccine Price List, 2020
Table 46 : Global Market for Vaccine Technologies for Pediatrics, by Region, Through 2026
Table 47 : Price List of Vaccines for Adults
Table 48 : Global Market for Vaccines for Adolescents and Adults, by Region, Through 2026
Table 49 : Global Market for Vaccine Technologies, by Region, Through 2026
Table 50 : North American Market for Vaccine Technologies, by Vaccine Type, Through 2026
Table 51 : North American Market for Vaccine Technologies, by Country, Through 2026
Table 52 : Immunization Schedule, Canada, 2020
Table 53 : European Market for Vaccine Technologies, by Vaccine Type, Through 2026
Table 54 : European Market for Vaccine Technologies, by Country, Through 2026
Table 55 : Immunization Schedule, Germany, 2020
Table 56 : Immunization Schedule, France, 2020
Table 57 : Vaccination and Immunization Schedule, U.K., 2020
Table 58 : Immunization Schedule, Italy, 2020
Table 59 : Asia-Pacific Market for Vaccine Technologies, by Vaccine Type, Through 2026
Table 60 : Asia-Pacific Market for Vaccine Technologies, by Country, Through 2026
Table 61 : Immunization Schedule, China, 2020
Table 62 : Immunization Schedule, Japan, 2020
Table 63 : Immunization Schedule, India, 2020
Table 64 : GAVI Support to India, 2001-2021
Table 65 : Vaccination Coverage Estimate, Middle East and North Africa, 2014-2020
Table 66 : Vaccination Coverage, Latin America, and Caribbean, 2014-2020
Table 67 : Rest of World Market for Vaccine Technologies, by Vaccine Type, Through 2026
Table 68 : AstraZeneca: Vaccines
Table 69 : AstraZeneca: Recent Developments, 2021
Table 70 : Bavarian Nordic A/S: Recent Developments, 2021
Table 71 : Bharat Biotech: Vaccines
Table 72 : Bharat Biotech: Recent Developments, 2021
Table 73 : Emergent BioSolutions Inc: Vaccines
Table 74 : Emergent BioSolutions Inc: Recent Developments, 2021
Table 75 : GlaxoSmithKline Plc: Vaccines Offered
Table 76 : GlaxoSmithKline Plc.: Recent Developments, 2021
Table 77 : Johnson & Johnson Inc.: Recent Developments, 2021
Table 78 : Merck & Co. Inc.: Vaccines
Table 79 : Merck & Co. Inc.: Recent Developments, 2021
Table 80 : Pfizer Inc.: Recent Developments 2021
Table 81 : Sanofi Pasteur SA: Vaccines
Table 82 : Sanofi Pasteur SA: Recent Developments, 2021
Table 83 : Acronyms Used in This Report

List of Figures

Summary Figure A : Global Market for Vaccine Technologies, by Vaccine Type, 2019-2026
Summary Figure B : Global Market for COVID-19 Vaccines, 2019-2026
Figure 1 : Global Market Share of COVID-19 Vaccines, by Technology, 2021
Figure 2 : Global Market Share for Vaccine Technologies, by Company, 2020
Figure 3 : Global Market Share for Vaccine Technologies, by Technology, 2020
Figure 4 : Global Market for Subunit, Recombinant, Polysaccha
Figure 5 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, by Region, 2019-2026
Figure 6 : Global Market for Live-Attenuated Vaccines, 2019-2026
Figure 7 : Global Market for Live-Attenuated Vaccines, by Region, 2019-2026
Figure 8 : Global Market for Inactivated Vaccines, 2019-2026
Figure 9 : Global Market for Inactivated Vaccines, by Region, 2019-2026
Figure 10 : Global Market for Toxoid Vaccines, 2019-2026
Figure 11 : Global Market for Toxoid Vaccines, by Region, 2019-2026
Figure 12 : Global Market for Other/Combination Vaccines, 2019-2026
Figure 13 : Global Market for Other/Combination Vaccines, by Region, 2019-2026
Figure 14 : Global Market Share of Vaccine Technologies, by Disease, 2020
Figure 15 : Global Market for Vaccine Technologies for Pneumococcal Disease, 2019-2026
Figure 16 : Global Market for Vaccine Technologies for Pneumococcal Disease, by Region, 2019-2026
Figure 17 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, 2019-2026
Figure 18 : Global Market for Vaccine Technologies for Diphtheria and Tetanus, by Region, 2019-2026
Figure 19 : Global Market for Vaccine Technologies for HPV, 2019-2026
Figure 20 : Global Market for Vaccine Technologies for HPV, by Region, 2019-2026
Figure 21 : Global Market for Vaccine Technologies for MMR, 2019-2026
Figure 22 : Global Market for Vaccine Technologies for MMR, by Region, 2019-2026
Figure 23 : Global Market for Vaccine Technologies for Other Diseases, 2019-2026
Figure 24 : Global Market for Vaccine Technologies for Other Diseases, by Region, 2019-2026
Figure 25 : Global Market Share of Vaccine Technologies, by Age Group Treated, 2020
Figure 26 : Global Market for Vaccine Technologies for Pediatrics, 2019-2026
Figure 27 : Global Market for Vaccine Technologies for Pediatrics, by Region, 2019-2026
Figure 28 : Global Market for Vaccines for Adolescents and Adults, 2019-2026
Figure 29 : Global Market for Vaccines for Adolescents and Adults, by Region, 2019-2026
Figure 30 : Global Market for Vaccine Technologies, by Region, 2019-2026
Figure 31 : Global Market Share of Vaccine Technologies, by Region, 2020
Figure 32 : North American Market Share for Vaccine Technologies, by Vaccine Type, 2020
Figure 33 : North American Market Share for Vaccine Technologies, by Country, 2020
Figure 34 : U.S. Market for Vaccine Technologies, 2019-2026
Figure 35 : Canadian Market for Vaccine Technologies, 2020-2026
Figure 36 : European Market Share for Vaccine Technologies, by Vaccine Type, 2020
Figure 37 : European Market Share for Vaccine Technologies, by Country, 2020
Figure 38 : German Market for Vaccine Technologies, 2019-2026
Figure 39 : Russian Market for Vaccine Technologies, 2019-2026
Figure 40 : French Market for Vaccine Technologies, 2019-2026
Figure 41 : U.K. Market for Vaccine Technologies, 2019-2026
Figure 42 : Italian Market for Vaccine Technologies, 2019-2026
Figure 43 : Spanish Market for Vaccine Technologies, 2019-2026
Figure 44 : Rest of European Market for Vaccine Technologies, 2019-2026
Figure 45 : Asia-Pacific Market Share for Vaccine Technologies, by Vaccine Type, 2020
Figure 46 : Asia-Pacific Market Share for Vaccine Technologies, by Country, 2020
Figure 47 : Chinese Market for Vaccine Technologies, 2019-2026
Figure 48 : Japanese Market for Vaccine Technologies, 2019-2026
Figure 49 : Australian Market for Vaccine Technologies, 2019-2026
Figure 50 : Indian Market for Vaccine Technologies, 2019-2026
Figure 51 : Korean Market for Vaccine Technologies, 2019-2026
Figure 52 : Rest of Asia-Pacific Market for Vaccine Technologies, 2019-2026
Figure 53 : Rest of World Market Share for Vaccine Technologies, by Technology, 2020
Figure 54 : Abbott Laboratories: Net Revenue, 2016-2020
Figure 55 : Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 56 : Abbott Laboratories: Revenue Share, by Region, 2020
Figure 57 : AstraZeneca: Net Revenue, 2016-2020
Figure 58 : AstraZeneca: Revenue Share, by Business Segment, 2020
Figure 59 : AstraZeneca: Revenue Share, by Region, 2020
Figure 60 : Bavarian Nordic A/S: Net Revenue, 2016-2020
Figure 61 : Bavarian Nordic A/S: Revenue Share, by Region, 2020
Figure 62 : Emergent BioSolutions Inc: Net Revenue, 2016-2020
Figure 63 : GlaxoSmithKline Plc: Net Revenue, 2016-2020
Figure 64 : GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2020
Figure 65 : GlaxoSmithKline Plc: Revenue Share, by Region, 2020
Figure 66 : Johnson & Johnson Inc.: Net Revenue, 2016-2020
Figure 67 : Johnson & Johnson Inc.: Revenue Share, by Business Segment, 2020
Figure 68 : Johnson & Johnson Inc.: Revenue Share, by Region, 2020
Figure 69 : Merck & Co. Inc.: Net Revenue, 2016-2020
Figure 70 : Merck & Co. Inc.: Revenue Share, by Business Segment, 2020
Figure 71 : Merck & Co. Inc.: Revenue Share, by Region, 2021
Figure 72 : Mitsubishi Tanabe Pharma Corp.: Net Revenue, 2016-2020
Figure 73 : Mitsubishi Tanabe Pharma Corp.: Revenue Share, by Business Segment, 2020
Figure 74 : Mitsubishi Tanabe Pharma Corp.: Revenue Share, by Region, 2020
Figure 75 : Panacea Biotec LTD.: Net Revenue, 2016-2020
Figure 76 : Panacea Biotec LTD: Revenue Share, by Business Segment, 2020
Figure 77 : Panacea Biotec LTD: Revenue Share, by Region, 2020
Figure 78 : Pfizer Inc.: Net Revenue, 2017-2021
Figure 79 : Pfizer Inc.: Revenue Share, by Region, 2021
Figure 80 : Sanofi Pasteur SA: Net Revenue, 2017-2021
Figure 81 : Sanofi Pasteur SA: Revenue Share, by Business Segment, 2020
Figure 82 : Sanofi Pasteur SA: Revenue Share, by Region, 2021


△ 一番上に戻る